ProShares Ultra Nasdaq Biotechnology BIB
124.13 USD +6.65 (+5.66%)
At closeNov 9, 2026, 4:00 PM EST
124.29 +0.16 +0.13%
After hours · Nov 9, 4:00 PM ET
120.00 Day range 125.00
70.26 52-week range 126.40
- YTD
- +55.59%
- 1 year
- +78.52%
- Market cap
- 102.43M
- EPS (ttm)
- 3.53
- P/E ratio
- 35.15
- YTD return
- +55.59%
- 1-year return
- +78.52%
- Volume
- 7.62K
- Avg volume
- 9.98K
- Open
- 120.00
- Previous close
- 117.48
- Day's range
- 120.00 – 125.00
- 52-week range
- 70.26 – 126.40
5D +5.88 (+4.97%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 59.52
- 200-day average
- 59.79
About ProShares Ultra Nasdaq Biotechnology
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
News
Your note
Sign in to keep a note on BIB — it syncs with the Stock Master app.